Pfizer Inc.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Total Cash from Operations: $16.19B
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $1.00B | 6.2% |
| Business Acquisitions | $10.11B | 62.4% |
| Stock Repurchases | $0 | 0.0% |
| Other Financing | $0 | 0.0% |
| Other | $5.08B | 31.4% |
| Net Cash Flow | $0 | 0.0% |